What’s inside:
CR Power (836 HK - BUY). Solid in changing times.
Shougang Fushan (639 HK - O-PF). Relative strength.
Ping An Insurance (2318 HK - BUY). A more competitive player.
Beijing Enterprises (392 HK - U-PF). Not enough gas.
Shun Tak (242 HK - BUY). Strengthened war chest.
FCLSA: A-share market strategy. Growth off a low base.
FCLSA: Sino-Biopharm (1177 HK - BUY). 1H13 results.
首页
微信公众号
证券之星APP
